ÂÜÀòÂÒÂ×

Jeff Moore has a comprehensive work experience in the pharmaceutical industry, with a focus on rare disease and cystic fibrosis. Jeff began their career as a Gastroenterology Sales Specialist at Aptalis in 2004, where they worked until 2012. After that, they joined Aptalis Pharmaceutical Technologies as a Cystic Fibrosis Account Manager, handling account management and formulary presentations to Cystic Fibrosis Centers and Surgical Oncology institutions. In 2014, Jeff worked as a Cystic Fibrosis Account Manager at Actavis plc (now Allergan) and Allergan until 2016. During this time, they concentrated on managing cystic fibrosis accounts and handling orphan rare diseases. From 2016 to 2018, they worked as a Rare Disease Account Manager at Alcresta Therapeutics, focusing on launching a novel device called Relizorb. Jeff covered CF Centers in various states, including Pennsylvania, Ohio, Kentucky, New York, and Michigan. Following this, Jeff joined Intercept Pharmaceuticals in 2018 as a Rare Disease Territory Business Manager, managing the territory until 2022. Currently, they work at Intercept Pharmaceuticals as a Territory Business Manager. Additionally, Jeff worked at Calliditas Therapeutics AB from 2022 until the present, serving as a Rare Disease Account Manager.

From 1990 to 1994, Jeff Moore attended Penn State University, where they earned a Bachelor of Applied Science (B.S.) degree in Hospitality Administration/Management.